Literature DB >> 21853369

Synthesis of monomethoxypolyethyleneglycol-cholesteryl ester and effect of its incorporation in liposomes.

Vinayak P Sant1, Mangal S Nagarsenker.   

Abstract

The objective of the present study was to synthesize monomethoxypolyethyleneglycol-5000 cholesteryl ester [PEG-CH] as a cost-effective substitute for polyethyleneglycol-phosphatidylethanolamine and to evaluate the influence of its incorporation in liposomal bilayers for surface modification. PEG-CH was synthesized and characterized by infrared (IR), proton nuclear magnetic resonance spectroscopy ((1)H NMR), and differential scanning calorimetry (DSC) studies. Influence of incorporation of PEG-CH in liposomes was evaluated on various parameters such as zeta potential, DSC, and encapsulation efficiency of a hydrophilic drug pentoxyfylline. Conventional and PEG-CH containing pentoxyfylline liposomes were formulated and their stability was evaluated at 4°C for 3 months. PEG-CH could be successfully synthesized with good yields and the structure was confirmed by IR, DSC, and (1)H NMR. The incorporation of PEG-CH in liposomes resulted in reduction of the zeta potential and broadening of the DSC endotherm. Furthermore, incorporation of PEG-CH in liposomes decreased the encapsulation efficiency of pentoxifylline in liposomes when compared to conventional liposomes. Conventional and PEG-CH containing pentoxyfylline liposomes did not show any signs of pentoxyfylline degradation when stored at 4°C for 3 months.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21853369      PMCID: PMC3225533          DOI: 10.1208/s12249-011-9674-2

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  16 in total

Review 1.  Recent advances with liposomes as pharmaceutical carriers.

Authors:  Vladimir P Torchilin
Journal:  Nat Rev Drug Discov       Date:  2005-02       Impact factor: 84.694

Review 2.  Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development.

Authors:  Daryl C Drummond; Charles O Noble; Mark E Hayes; John W Park; Dmitri B Kirpotin
Journal:  J Pharm Sci       Date:  2008-11       Impact factor: 3.534

Review 3.  Liposomal nanomedicines as anticancer therapeutics: beyond targeting tumor cells.

Authors:  Raymond M Schiffelers; Gert Storm
Journal:  Int J Pharm       Date:  2008-08-19       Impact factor: 5.875

4.  The antimalarial agent halofantrine perturbs phosphatidylcholine and phosphatidylethanolamine bilayers: a differential scanning calorimetric study.

Authors:  L Y Lim; M L Go
Journal:  Chem Pharm Bull (Tokyo)       Date:  1999-06       Impact factor: 1.645

5.  Effects of polyethyleneglycol chain length and phospholipid acyl chain composition on the interaction of polyethyleneglycol-phospholipid conjugates with phospholipid: implications in liposomal drug delivery.

Authors:  F K Bedu-Addo; P Tang; Y Xu; L Huang
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

6.  Interaction of polyethyleneglycol-phospholipid conjugates with cholesterol-phosphatidylcholine mixtures: sterically stabilized liposome formulations.

Authors:  F K Bedu-Addo; P Tang; Y Xu; L Huang
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

7.  Synthesis and application of poly(ethylene glycol)-cholesterol (Chol-PEGm) conjugates in physicochemical characterization of nonionic surfactant vesicles.

Authors:  Dan-bo Yang; Jia-bi Zhu; Zhang-jian Huang; Hai-xia Ren; Zeng-juan Zheng
Journal:  Colloids Surf B Biointerfaces       Date:  2007-12-08       Impact factor: 5.268

Review 8.  Liposomal drug delivery systems: an update review.

Authors:  Abdus Samad; Y Sultana; M Aqil
Journal:  Curr Drug Deliv       Date:  2007-10       Impact factor: 2.565

9.  The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.

Authors:  S Dadashzadeh; A M Vali; M Rezaie
Journal:  Int J Pharm       Date:  2007-11-23       Impact factor: 5.875

Review 10.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.

Authors:  Maria Laura Immordino; Franco Dosio; Luigi Cattel
Journal:  Int J Nanomedicine       Date:  2006
View more
  1 in total

1.  PEGylated Lipova E120 liposomes loaded with celecoxib: in-vitro characterization and enhanced in-vivo anti-inflammatory effects in rat models.

Authors:  Vivek Dave; Ashish Gupta; Priyanka Singh; Kajal Tak; Swapnil Sharma
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.